CASZ1 Inhibits Cell Cycle Progression in Neuroblastoma by Restoring PRb Activity

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2013 Jul 30

PMID 23892435

Citations 21

Authors

Zhihui Liu

JulieAnn Rader

Stanley He

Tanya Phung

Carol J Thiele

Affiliations

Soon will be listed here.

Abstract

Dysregulation of cell cycle genes such as Cyclin D1 and Chk1 contributes to the undifferentiated phenotype of neuroblastoma (NB). CASZ1 functions as a tumor suppressor in NB; here we sought to determine how loss of CASZ1 contributes to cell cycle dysregulation in NB. CASZ1 restoration in NB cells delays NB cell cycle progression. The earliest changes occur within 8 h of CASZ1 restoration in SY5Y cells with a 2.8-fold increase in the level of p21, an inhibitor of Cdk2/4. By 16 h, there is a 40% decrease in the steady-state levels of Cdk6. Restoration of CASZ1 decreases Cdk2-dependent cyclins A and E protein levels and Cdk4/6-dependent Cyclin D1 protein levels. The restoration of CASZ1 resulted in a decrease in pRb phosphorylation and a significant reduction of E2F transcriptional activity. Subsequent to the changes in the G 1/S transition, induction of CASZ1 results in a decrease in Cyclin B levels and Cdc25c phosphatase levels, an upstream activator of the G 2/M regulator CyclinB:Cdk1. In addition, induction of CASZ1 results in a decrease in the levels of phospho-Chk1, a key M-phase regulatory kinase. Similar results were found in a NB cell line with MYCN amplification. Taken together, this study indicates that restoration of CASZ1 activates pRb in G 1 and inhibits the G 2/M regulators Cyclin B1 and Chk1, leading to a lengthening of NB cell cycle progression and a subsequent decrease in cell proliferation.

Citing Articles

Role of the CASZ1 transcription factor in tissue development and disease.

Liu T, Li T, Ke S Eur J Med Res. 2023; 28(1):562.

PMID: 38053207 PMC: 10696751. DOI: 10.1186/s40001-023-01548-y.

: Current Implications in Cardiovascular Diseases and Cancers.

Jian H, Poetsch A Biomedicines. 2023; 11(7).

PMID: 37509718 PMC: 10377389. DOI: 10.3390/biomedicines11072079.

Zinc finger transcription factor CASZ1b is involved in the DNA damage response in live cells.

Liu Z, Kruhlak M, Thiele C Biochem Biophys Res Commun. 2023; 663:171-178.

PMID: 37121127 PMC: 10880029. DOI: 10.1016/j.bbrc.2023.04.085.

Comparison among Neuroblastoma Stages Suggests the Involvement of Mitochondria in Tumor Progression.

Cagnin S, Knedlik T, Vianello C, Magalhaes Rebelo A, De Mario A, Giacomello M Biomedicines. 2023; 11(2).

PMID: 36831133 PMC: 9953471. DOI: 10.3390/biomedicines11020596.

Loss of CASZ1 tumor suppressor linked to oncogenic subversion of neuroblastoma core regulatory circuitry.

Liu Z, Zhang X, Xu M, Lei H, Shern J, Thiele C Cell Death Dis. 2022; 13(10):871.

PMID: 36243768 PMC: 9569368. DOI: 10.1038/s41419-022-05314-6.

References

Lundberg A, Weinberg R . Control of the cell cycle and apoptosis. Eur J Cancer. 1999; 35(4):531-9. View

Christine K, Conlon F . Vertebrate CASTOR is required for differentiation of cardiac precursor cells at the ventral midline. Dev Cell. 2008; 14(4):616-23. PMC: 2807748. DOI: 10.1016/j.devcel.2008.01.009. View

Blagosklonny M, Pardee A . The restriction point of the cell cycle. Cell Cycle. 2002; 1(2):103-10. View

Liu Q, Guntuku S, Cui X, Matsuoka S, Cortez D, Tamai K . Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 2000; 14(12):1448-59. PMC: 316686. View

Chellappan S, Hiebert S, Mudryj M, Horowitz J, Nevins J . The E2F transcription factor is a cellular target for the RB protein. Cell. 1991; 65(6):1053-61. DOI: 10.1016/0092-8674(91)90557-f. View

Baldi A, De Luca A, Esposito V, Campioni M, Spugnini E, Citro G . Tumor suppressors and cell-cycle proteins in lung cancer. Patholog Res Int. 2011; 2011:605042. PMC: 3189597. DOI: 10.4061/2011/605042. View

Mellerick D, Kassis J, Zhang S, Odenwald W . castor encodes a novel zinc finger protein required for the development of a subset of CNS neurons in Drosophila. Neuron. 1992; 9(5):789-803. DOI: 10.1016/0896-6273(92)90234-5. View

Liu Z, Yang X, Tan F, Cullion K, Thiele C . Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation. Biochem Biophys Res Commun. 2006; 344(3):834-44. DOI: 10.1016/j.bbrc.2006.03.207. View

Paternot S, Bockstaele L, Bisteau X, Kooken H, Coulonval K, Roger P . Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell Cycle. 2010; 9(4):689-99. DOI: 10.4161/cc.9.4.10611. View

10.

Hartwell L, Kastan M . Cell cycle control and cancer. Science. 1994; 266(5192):1821-8. DOI: 10.1126/science.7997877. View

11.

Bracken A, Ciro M, Cocito A, Helin K . E2F target genes: unraveling the biology. Trends Biochem Sci. 2004; 29(8):409-17. DOI: 10.1016/j.tibs.2004.06.006. View

12.

Gaetano C, Matsumoto K, Thiele C . In vitro activation of distinct molecular and cellular phenotypes after induction of differentiation in a human neuroblastoma cell line. Cancer Res. 1992; 52(16):4402-7. View

13.

Senderowicz A . Targeting cell cycle and apoptosis for the treatment of human malignancies. Curr Opin Cell Biol. 2004; 16(6):670-8. DOI: 10.1016/j.ceb.2004.09.014. View

14.

Schmitz M, Driesch C, Beer-Grondke K, Jansen L, Runnebaum I, Durst M . Loss of gene function as a consequence of human papillomavirus DNA integration. Int J Cancer. 2012; 131(5):E593-602. DOI: 10.1002/ijc.27433. View

15.

Ho A, Dowdy S . Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev. 2002; 12(1):47-52. DOI: 10.1016/s0959-437x(01)00263-5. View

16.

Schwartz G, Shah M . Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol. 2005; 23(36):9408-21. DOI: 10.1200/JCO.2005.01.5594. View

17.

Vermeulen K, Bockstaele D, Berneman Z . The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003; 36(3):131-49. PMC: 6496723. DOI: 10.1046/j.1365-2184.2003.00266.x. View

18.

Wang C, Liu Z, Woo C, Li Z, Wang L, Wei J . EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res. 2011; 72(1):315-24. PMC: 3487161. DOI: 10.1158/0008-5472.CAN-11-0961. View

19.

Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L . CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ. 2011; 18(7):1174-83. PMC: 3131958. DOI: 10.1038/cdd.2010.187. View

20.

Henrich K, Schwab M, Westermann F . 1p36 tumor suppression--a matter of dosage?. Cancer Res. 2012; 72(23):6079-88. DOI: 10.1158/0008-5472.CAN-12-2230. View